Study on the Preparation of Hepatitis B-BCG Combined Vaccine
Lijie Jin
Abstract
Lijie Jin
Abstract
To prepare the Hepatitis B-BCG combined vaccine, the hepatitis B surface antigen( HBsAg)was prepared by genetic engineering technique and BCG was produced using routine biological technique, then the final product of the hepatitis B-BCG combined vaccine was processed by freeze-drying. The stability and efficacy on freeze-dry antigen were also studied .The immune response, safety,partial toxicity,and allergy were tested using different animals. Results found that the freeze-drying technique had no effect on antigen; also no significant difference in the relative efficacy among the combined vaccine or BCG(P0.05);The Hepatitis B vaccine was the same (P0.05); The safety in hepatitis B-BCG combined vaccine group was accorded with that in BCG group, and the tuberculosis was not seen. The process in pathological changes of hepatitis B-BCG combined vaccine group and BCG group was similar. HBsAg did not strengthen the inflammation reaction caused by BCG. In addition the allergy was not found in experment.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
To prepare the Hepatitis B-BCG combined vaccine, the hepatitis B surface antigen( HBsAg)was prepared by genetic engineering technique and BCG was produced using routine biological technique, then the final product of the hepatitis B-BCG combined vaccine was processed by freeze-drying. The stability and efficacy on freeze-dry antigen were also studied .The immune response, safety,partial toxicity,and allergy were tested using different animals. Results found that the freeze-drying technique had no effect on antigen; also no significant difference in the relative efficacy among the combined vaccine or BCG(P0.05);The Hepatitis B vaccine was the same (P0.05); The safety in hepatitis B-BCG combined vaccine group was accorded with that in BCG group, and the tuberculosis was not seen. The process in pathological changes of hepatitis B-BCG combined vaccine group and BCG group was similar. HBsAg did not strengthen the inflammation reaction caused by BCG. In addition the allergy was not found in experment.
Key concepts: HBsAg, Medicine, Hepatitis B vaccine, Hepatitis B, Antigen, Immunology, Tuberculosis, BCG vaccine